Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > FL Providers

Dr. Manmeet Singh Ahluwalia, MD

Accepting New Patients

(Manmeet Singh Ahluwalia, MD)

(3 Ratings)

Specializes in: Medical Oncology, Oncology (Cancer Care) and Hematology (Blood Disorders)

Maulana Azad Medical College (2001)

8900 N Kendall Drive
Miami, FL 33176

(786) 596-2000

Dr. Manmeet Singh Ahluwalia, MD is a medical oncologist in Miami, FL specializing in medical oncology, oncology (cancer care) and hematology (blood disorders). He graduated from Maulana Azad Medical College in 2001 and has 25 years of experience. Dr. Manmeet Singh Ahluwalia, MD is affiliated with Baptist Health, BAPTIST HEALTH MEDICAL GROUP ONCOLOGY LLC and Baptist Health Herbert Wertheim Cancer Institute.

Office Locations

8900 N Kendall Drive
Miami, FL 33176

open_in_new

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

The top procedures that Dr. Manmeet Singh Ahluwalia, MD treated as a medical oncologist in Miami, FL during 2012 were hospital care and inpatient care.

Volume of procedures performed by Dr. Manmeet Singh Ahluwalia, MD for Medicare patients.

doctor visit	79
hospital care	99
inpatient care	99

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

Volume of procedures performed by Dr. Manmeet Singh Ahluwalia, MD for Medicare patients.

doctor visit	89

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Manmeet Singh Ahluwalia, MD.

**Gender**
Male	32
Female	16

**Age**
From 65 to 74	26
From 75 to 84	0
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Manmeet Singh Ahluwalia, MD in 2013

Hypertension	73
High Cholesterol	52
Stroke	0
Ischemic Heart Disease	0
Depression	33
Chronic Kidney Disease	23
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	25
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

Volume of procedures performed by Dr. Manmeet Singh Ahluwalia, MD for Medicare patients.

doctor visit	109

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Manmeet Singh Ahluwalia, MD.

**Gender**
Male	33
Female	28

**Age**
From 65 to 74	35
From 75 to 84	0
85 and over	0
Less than 65	13

Conditions of Medicare patients treated by Dr. Manmeet Singh Ahluwalia, MD in 2014

Hypertension	67
High Cholesterol	46
Stroke	0
Ischemic Heart Disease	26
Depression	36
Chronic Kidney Disease	25
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	34
Dementia	0
Cancer	18

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. Manmeet Singh Ahluwalia, MD treated as a medical oncologist in Miami, FL during 2015 were hospital care and inpatient care.

Volume of procedures performed by Dr. Manmeet Singh Ahluwalia, MD for Medicare patients.

doctor visit	136
hospital care	36
inpatient care	36

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Manmeet Singh Ahluwalia, MD.

**Gender**
Male	96
Female	48

**Age**
From 65 to 74	78
From 75 to 84	32
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Manmeet Singh Ahluwalia, MD in 2015

Hypertension	71
High Cholesterol	46
Stroke	0
Ischemic Heart Disease	31
Depression	28
Chronic Kidney Disease	33
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	22
Chronic Obstructive Pulmonary Disease	0
Diabetes	26
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

Volume of procedures performed by Dr. Manmeet Singh Ahluwalia, MD for Medicare patients.

doctor visit	168

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Manmeet Singh Ahluwalia, MD.

**Gender**
Male	36
Female	30

**Age**
From 65 to 74	37
From 75 to 84	0
85 and over	0
Less than 65	17

Conditions of Medicare patients treated by Dr. Manmeet Singh Ahluwalia, MD in 2016

Hypertension	58
High Cholesterol	36
Stroke	17
Ischemic Heart Disease	26
Depression	29
Chronic Kidney Disease	27
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	32
Dementia	23
Cancer	0

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

The top procedures that Dr. Manmeet Singh Ahluwalia, MD treated as a medical oncologist in Miami, FL during 2017 were hospital care and inpatient care.

Volume of procedures performed by Dr. Manmeet Singh Ahluwalia, MD for Medicare patients.

doctor visit	154
hospital care	24
inpatient care	24

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Manmeet Singh Ahluwalia, MD.

**Gender**
Male	54
Female	35

**Ethnicity**
Non-Hispanic White	77
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	55
From 75 to 84	0
85 and over	0
Less than 65	21

Conditions of Medicare patients treated by Dr. Manmeet Singh Ahluwalia, MD in 2017

Hypertension	64
High Cholesterol	43
Stroke	22
Ischemic Heart Disease	34
Depression	39
Chronic Kidney Disease	42
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	18
Chronic Obstructive Pulmonary Disease	15
Diabetes	26
Dementia	18
Cancer	22

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

The top procedures that Dr. Manmeet Singh Ahluwalia, MD treated as a medical oncologist in Miami, FL during 2018 were hospital care and inpatient care.

Volume of procedures performed by Dr. Manmeet Singh Ahluwalia, MD for Medicare patients.

doctor visit	141
hospital care	21
inpatient care	21

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Manmeet Singh Ahluwalia, MD.

**Gender**
Male	45
Female	37

**Ethnicity**
Non-Hispanic White	71
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	43
From 75 to 84	0
85 and over	0
Less than 65	18

Conditions of Medicare patients treated by Dr. Manmeet Singh Ahluwalia, MD in 2018

Hypertension	65
High Cholesterol	49
Stroke	20
Ischemic Heart Disease	29
Depression	37
Chronic Kidney Disease	38
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	17
Chronic Obstructive Pulmonary Disease	0
Diabetes	30
Dementia	13
Cancer	22

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. Manmeet Singh Ahluwalia, MD treated as a medical oncologist in Miami, FL during 2019 were hospital care and inpatient care.

Volume of procedures performed by Dr. Manmeet Singh Ahluwalia, MD for Medicare patients.

doctor visit	130
hospital care	72
inpatient care	72

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Manmeet Singh Ahluwalia, MD.

**Gender**
Male	47
Female	52

**Ethnicity**
Non-Hispanic White	83
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	49
From 75 to 84	26
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Manmeet Singh Ahluwalia, MD in 2019

Hypertension	72
High Cholesterol	54
Stroke	20
Ischemic Heart Disease	28
Depression	39
Chronic Kidney Disease	43
Asthma	0
Osteoperosis	0
Atrial Fibrilation	14
Heart Failure	15
Chronic Obstructive Pulmonary Disease	0
Diabetes	34
Dementia	18
Cancer	23

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

The top procedures that Dr. Manmeet Singh Ahluwalia, MD treated as a medical oncologist in Miami, FL during 2020 were hospital care and inpatient care.

Volume of procedures performed by Dr. Manmeet Singh Ahluwalia, MD for Medicare patients.

doctor visit	25
hospital care	29
inpatient care	29

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Manmeet Singh Ahluwalia, MD.

**Gender**
Male	32
Female	26

**Age**
From 65 to 74	31
From 75 to 84	16
85 and over	0
Less than 65	11

Conditions of Medicare patients treated by Dr. Manmeet Singh Ahluwalia, MD in 2020

Hypertension	55
High Cholesterol	47
Stroke	0
Ischemic Heart Disease	26
Depression	26
Chronic Kidney Disease	29
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	22
Dementia	0
Cancer	29

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2020

Volume of procedures performed by Dr. Manmeet Singh Ahluwalia, MD for Medicare patients.

The highest averages for the top procedures that Dr. Manmeet Singh Ahluwalia, MD treated as a medical oncologist in Miami, FL were hospital care and inpatient care.

doctor visit	114
hospital care	46
inpatient care	46

Average Medicare Patient Data From 2012 - 2020

Information about Medicare patients treated by Dr. Manmeet Singh Ahluwalia, MD.

**Gender**
Female	30
Male	41

**Ethnicity**
Black / African American	0
Asian / Pacific Islander	0
Non-Hispanic White	25
Hispanic	0
Native American / Alaskan Native	0
Other	0

**Age**
85 and over	0
75 to 84	8
Less than 65	8
65 to 74	39

Average of Total of Conditions of Medicare patients treated by Dr. Manmeet Singh Ahluwalia, MD From 2012 - 2020

The highest averages of the most common conditions of Medicare patients that Dr. Manmeet Singh Ahluwalia, MD treated were hypertension, high cholesterol, chronic kidney disease and depression.

Hypertension	58
High Cholesterol	41
Stroke	8
Ischemic Heart Disease	22
Depression	29
Chronic Kidney Disease	28
Asthma	0
Osteoporosis	0
Heart Failure	8
Chronic Obstructive Pulmonary Disease	1
Diabetes	25
Atrial Fibrillation	1
Cancer	12
Dementia	8

Education & Training

Dr. Manmeet Singh Ahluwalia, MD graduated from Maulana Azad Medical College in 2001. He completed residency at Fairview Hospital, Program, Internal Medicine. He is certified by the Internal Medicine, American Board of Internal Medicine, Medical Oncology, American Board of Internal Medicine and has a state license in Ohio.

Medical School: Maulana Azad Medical College (2001)

Residency: Fairview Hospital, Program, Internal Medicine (2006)

Board Certification: Internal Medicine, American Board of Internal Medicine, Medical Oncology, American Board of Internal Medicine (2006)

Licensed In: Ohio

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Manmeet Singh Ahluwalia, MD appears to accept the following insurance providers: Tricare Prime, HealthSpring, Avmed Commercial, Preferred Care Network (A UnitedHealthcare company – United MedicareMax), Medicare, Medicaid, Humana Medicare, Cigna Commercial and Great West, Care Plus, First Health Network, Claritev - PHCS (a Multiplan Company), Molina Medicaid (CMS Title 19, Doctors HealthCare Plans, 21 & MMA), Florida Blue Commercial and Exchange (PCPs excluded from MyBlue), Florida Blue Medicare HMO, Tricare Select, Oscar Health Plan, Aetna Commercial, Florida Community Care, Devoted Health, Dimension Health, MultiPlan, Aetna, TRICARE, Preferred Care Network fka Medica, United HlthCare, FL Blue, Dimension International, Aetna Better Health/Healthy Kids and Global Excel.

Insurance Accepted by Provider includes:

According to our sources, Dr. Manmeet Singh Ahluwalia, MD accepts the following insurance providers:

Tricare Prime

HealthSpring

Avmed Commercial

Preferred Care Network (A UnitedHealthcare company – United MedicareMax)

Medicare

Medicaid

Humana Medicare

Cigna Commercial and Great West

Care Plus

First Health Network

Claritev - PHCS (a Multiplan Company)

Molina Medicaid (CMS Title 19

Doctors HealthCare Plans

21 & MMA)

Florida Blue Commercial and Exchange (PCPs excluded from MyBlue)

Florida Blue Medicare HMO

Tricare Select

Oscar Health Plan

Aetna Commercial

Florida Community Care

Devoted Health

Dimension Health

MultiPlan

Aetna

TRICARE

Preferred Care Network fka Medica

United HlthCare

FL Blue

Dimension International

Aetna Better Health/Healthy Kids

Global Excel

Ratings & Reviews

Dr. Manmeet Singh Ahluwalia, MD has an exceptional overall rating with an average of 5.0 out of 5 stars based on 3 ratings. We collect ratings and reviews of Dr. Manmeet Singh Ahluwalia, MD from all over the web to help you find the right in Miami, FL.

Overall Rating

(3 Ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Manmeet Singh Ahluwalia, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
AbbVie, Inc.	$40,585 Venclexta $4,980	$35,606
Monteris Medical Corporation	$32,242 NeuroBlate $32,242
Novocure Inc.	$27,529 Optune $13,591	NovoTTF-100A $10,367	Oncology $3,137	$434
Bayer HealthCare Pharmaceuticals Inc.	$26,716 Vitrakvi $8,559	Stivarga $2,282	Non-Covered $1,905	$13,970
AstraZeneca Pharmaceuticals LP	$20,287 TAGRISSO $12,416	LYNPARZA $107	Enhertu $20	$7,744
Other	$98,897 Exablate $14,092	JAKAFI $9,110	Sylvant $4,410	MRIDIAN $3,400	Avastin $3,018	Other $64,867

**Types of Payments**
Consulting Fee	$175,657
Travel and Lodging	$32,853
Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program	$13,500
Food and Beverage	$10,356
Honoraria	$7,800
Other	$6,091

Research Payments

Dr. Manmeet Singh Ahluwalia, MD has received 233 research payments totaling $7,038,170.

Biography

Manmeet Ahluwalia, M.D., MBA, FASCO, is the chief scientific officer, chief of medical oncology, deputy director and Fernandez Family Endowed Chair in Cancer Research at Baptist Health Herbert Wertheim Cancer Institute. As a neuro-oncologist, Dr. Ahluwalia’s primary areas of research and patient care are primary brain tumors (tumors originating in the brain that can be cancerous or noncancerous) and brain metastases (cancer that originated elsewhere in the body and has spread to the brain). Dr. Ahluwalia is fluent in English, Hindi and Punjabi. In 2025, Dr. Manmeet S. Ahluwalia was elected to the American Society for Clinical Investigation (ASCI), one of the oldest and most respected medical honor societies in the United States. This prestigious recognition honors physician-scientists under 50 who have made significant contributions to medical research and clinical care. Dr. Ahluwalia's election marks a historic milestone, as he is the first member from both Baptist Health South Florida and Florida International University Herbert Wertheim College of Medicine to be inducted into the ASCI. Dr. Ahluwalia completed internal medicine training at Cleveland Clinic Health System and fellowship training at Roswell Park Cancer Institute in 2009. He joined Cleveland Clinic, Ohio and soon became the Miller Family Endowed Chair in Neuro-Oncology and the head of operations at Burkhardt Brain Tumor and Neuro-Oncology Center in 2015. He became a full Professor at Cleveland Clinic Lerner College of Medicine at Case Western Reserve University in 2017. Dr. Ahluwalia obtained an MBA from Case Western - Weatherhead School of Management. Soon after, he moved to Herbert Wertheim Cancer Institute, intending to build the largest cancer program in South Florida. Alongside his leadership responsibilities, Dr. Ahluwalia holds the Fernandez Family Foundation Endowed Chair in Cancer Research at the Institute. Dr. Ahluwalia is driven by a passion for conquering brain tumors, having seen his grandmother succumb to cancer. For over a decade, he has led practice-changing research for developing new therapies for patients with primary brain tumors and brain metastases, resulting in his 250+ peer- reviewed papers. He designed and led the initial studies on combining immunotherapy/targeted therapy and radiosurgery in brain metastases. He co-led the first-in-man trial of Laser Interstitial Thermal Therapy (LITT) for primary brain tumors, which led to US FDA approval. He also designed and led the LASSR trial exploring LITT for brain metastases and radiation necrosis. He also first authored the landmark paper describing the Phase II trial of SurVaxM for glioblastoma in the Journal of Clinical Oncology.Along with a busy practice, he serves as the Principal Investigator (PI) on a $3.9 million NIH R01-funded grant on quantitative imaging phenotypic classifier development for radiomics in glioblastoma. This is the first NIH R01 grant ever received by Baptist Health. He is also the ‘clinical trial leader’ on the $10.4 million PO1 grant focusing on Glioblastoma gender-specific differences (Cosine Consortium). He is the PI on ongoing paradigm-changing FDA-approval-intent studies on blood- brain barrier disruption by Insightec Neuroblate (LIMITLESS, LIBERATE) through Low-Intensity Focused Ultrasound for primary brain tumors and brain metastases. He also chairs the scientific advisory committee of Guardian Research Network (GRN), a nationwide healthcare alliance. Dr. Ahluwalia has been a leader in organized efforts in neuro-oncology. He currently serves as the chair of the US National Cancer Institute (NCI) South-West Oncology Group (SWOG) Brain Tumor Working Group and the DEI co-chair of SWOG. He also chairs the Scientific Review Committee of the International Gamma Knife Research Foundation. He also serves as a member of the National Brain Tumor Society (NBTS) Roundtable Committee and as founder PI of the coordinating site for the International Radiosurgery Research Foundation. Dr. Ahluwalia has received several prestigious awards, including the Fellowship of the Am